CD47 Contributes to the Proliferation of Breast Cancer
Frontiers in Bioscience-Landmark · 2025
DOI: 10.31083/fbl28210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Junbin Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medicine School, Shandong University of Traditional Chinese Medicine, 250014 Jinan, Shandong, China. Hauptthemen laut MEDLINE: CD47 Antigen, Breast Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Development Program of Shandong Geriatrics Society, Scientific research cultivation fund of Shandong provincial third hospital, Medical and Health Science and Technology Project of Shandong Province.
Abstract (Originalsprache)
Background
The CD47 molecule (CD47) performs a novel role in regulating immunoreactions by binding to signal-regulatory protein alpha (SIRPα), resulting in the tumorigenesis of multiple malignant neoplasms. However, its effects and mechanisms in breast cancer (BC) remain unknown.
Methods
To explore the molecular mechanisms and explicit impacts of CD47, we screened two databases for CD47-associated signaling pathways and cellular functions. BC samples and patients’ basic information were collected to identify the statistical significance of CD47 expression. We also constructed experiments to validate the regulatory role of CD47 in BC cell proliferation.
Results
Analysis of the TCGA-BRCA, GSE42568, and GSE15852 datasets demonstrated an elevated level of CD47 in BC tissues. A Venn diagram revealed 11,194 co-expressed genes, and pathway analysis linked elevated CD47 levels to critical signaling pathways, such as cytokine-receptor interactions and Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling, which are integral to cell proliferation and invasiveness. Clinical data from 108 BC specimens showed that CD47 localization was primarily membranous, with higher levels correlating with proliferation marker Ki-67 (Ki-67) expression (p < 0.0001) and advanced tumor/node/metastasis (TNM) stage (p < 0.0001). Additionally, functional assays demonstrated that CD47 depletion reduced cell viability (p < 0.01), migration (p < 0.001), and invasion (p < 0.05 in 4T1 cells; p < 0.001 in MDA-MB-231 cells) in vitro and led to smaller tumor volumes (p < 0.0001) in vivo.
Conclusion
CD47 is a key regulator of BC cell proliferation and invasiveness and serves as a potential marker for assessing tumor aggressiveness and guiding therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Clinical Medicine School, Shandong University of Traditional Chinese Medicine, 250014 Jinan, Shandong, China.
- Department of Oncology, Shandong Provincial Third Hospital, 250031 Jinan, Shandong, China.
- Department of General Surgery, The First Rehabilitation Hospital of Shandong, 276000 Linyi, Shandong, China.
- Department of Breast and Thyroid Surgery, Shandong Provincial Third Hospital, 250031 Jinan, Shandong, China.
Förderung
- Science and Technology Development Program of Shandong Geriatrics Society
- Scientific research cultivation fund of Shandong provincial third hospital
- Medical and Health Science and Technology Project of Shandong Province
Zitieren
APA
Wang, J., Wu, X., Liu, X., & Xu, Y. (2025). CD47 Contributes to the Proliferation of Breast Cancer. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl28210
Vancouver
Wang J, Wu X, Liu X, Xu Y. CD47 Contributes to the Proliferation of Breast Cancer. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl28210
BibTeX
@article{Wang2025,
author = {Wang, Junbin and Wu, Xia and Liu, Xuejian and Xu, Ying},
title = {CD47 Contributes to the Proliferation of Breast Cancer},
journal = {Frontiers in Bioscience-Landmark},
year = {2025},
doi = {10.31083/fbl28210}
}
EUVIMED